CYTK
#918
Cytokinetics, Incorporated - Common Stock
72.0 9 USD
-0.07%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-7.46%
Changement Mensuel
-6.00%
Evolution sur 6 mois
+16.99%
Changement Annuel
+24.08%
Clôture Précédente
77.9 0
Open
72.1 6
Low
72.0 9
High
72.1 6
Volume
238
Financials
- Market Capitalization 10.02 B
- Employee 673
- Founded 1997
- CEO Robert I. BlumRobert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-11.78
ratio cours/chiffre d'affaires
0.16
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 891 |  KRYS Krystal Biotech, Inc. - Common Stock | 351.46 USD | -1.68% | +2.31% | +9.59% | +87.82% | 10.40 B USD | ||
| 910 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 61.05 USD | -2.21% | +0.74% | +15.93% | -15.36% | 10.15 B USD | ||
| 923 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.08 USD | -2.16% | -1.54% | +5.67% | +96.95% | 9.93 B USD | ||
| 931 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.15 USD | -1.73% | -0.39% | +14.97% | +99.92% | 9.82 B USD |